data_1qkf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qkf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 4.4000000000000004 109.582 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 p -131.19 136.62 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.585 -0.95 . . . . 3.1400000000000001 110.239 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.685 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -131.31 146.59 52.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.542 -0.723 . . . . 2.04 110.121 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.419 ' CG2' HG23 ' A' ' 41' ' ' VAL . 12.7 p -108.58 121.09 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.524 -0.917 . . . . 1.76 108.524 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.685 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 36.4 t70 -51.35 105.12 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.507 -0.746 . . . . 1.96 111.023 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -66.09 -24.97 66.8 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.728 -0.842 . . . . 1.47 108.728 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -26.88 67.7 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.137 0.494 . . . . 2.1699999999999999 109.98 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.6 ' HG ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -80.55 -37.19 31.9 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.186 -1.042 . . . . 1.3600000000000001 108.186 178.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.6 HD13 ' HG ' ' A' ' 15' ' ' LEU . 4.5 mp -64.04 -41.29 97.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.841 -0.537 . . . . 1.3400000000000001 109.807 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -55.93 -22.5 26.48 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.716 -0.615 . . . . 1.3200000000000001 110.434 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.499 ' HB2' HG22 ' A' ' 31' ' ' ILE . 33.6 mttt -101.8 -28.36 12.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.408 -0.808 . . . . 3.3300000000000001 110.317 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.553 HG13 ' HE2' ' A' ' 44' ' ' MET . 0.8 OUTLIER -74.77 -37.15 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.387 -0.82 . . . . 1.3899999999999999 111.044 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -62.18 -28.62 69.79 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.951 -1.129 . . . . 2.4700000000000002 107.951 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -36.02 71.62 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.48 -0.933 . . . . 2.4700000000000002 108.48 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 2.5 mt -75.49 -25.72 57.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.695 -0.628 . . . . 2.0299999999999998 109.886 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -83.76 -18.53 37.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.531 -0.73 . . . . 0.51000000000000001 109.565 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.29 -38.79 17.16 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.574 -0.703 . . . . 1.1599999999999999 109.813 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -89.27 -26.61 21.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.142 -0.688 . . . . 4.3899999999999997 109.142 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.57 14.32 47.69 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.128 -1.589 . . . . 0.84999999999999998 109.128 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 19.6 mt-10 -78.71 126.98 31.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.408 -1.054 . . . . 2.4300000000000002 110.392 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -101.32 74.79 1.58 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.533 -0.729 . . . . 3.3500000000000001 109.531 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.87 -153.12 0.51 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.536 -0.727 . . . . 4.5099999999999998 110.156 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -119.05 152.76 35.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.787 . . . . 1.4399999999999999 110.928 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.499 HG22 ' HB2' ' A' ' 18' ' ' LYS . 2.7 mp -125.94 116.51 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.85 -0.796 . . . . 1.3999999999999999 108.85 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.555 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 5.9 mptt -78.64 156.63 28.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.35 -0.844 . . . . 3.27 111.395 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.435 HG21 ' CG ' ' A' ' 12' ' ' ASP . 11.9 m -142.97 148.42 36.81 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.758 -0.589 . . . . 1.8300000000000001 110.003 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.587 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -147.68 50.47 1.06 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.329 -0.857 . . . . 1.02 111.053 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.69 -94.33 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.939 -1.101 . . . . 1.4399999999999999 110.632 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.3 ttm-85 -163.99 -65.36 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.988 -1.07 . . . . 5.1900000000000004 110.172 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.41 28.99 3.42 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.403 -0.81 . . . . 4.5800000000000001 109.75 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.5 m -38.4 123.12 1.15 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.562 0.696 . . . . 0.79000000000000004 112.126 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.9 m -127.05 161.29 28.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.923 -0.486 . . . . 1.1100000000000001 109.748 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.628 HG22 ' CG2' ' A' ' 62' ' ' ILE . 4.3 mp -81.93 167.07 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.286 -0.884 . . . . 1.6100000000000001 111.227 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG21 ' HG2' ' A' ' 44' ' ' MET . 0.1 OUTLIER -140.04 176.72 2.37 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 109.259 -0.645 . . . . 1.29 109.259 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.8 Cg_endo -66.11 -32.76 42.66 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.944 1.497 . . . . 0.76000000000000001 111.035 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.92 -9.81 42.08 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.637 -0.664 . . . . 2.6499999999999999 110.612 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.574 ' HG2' HG21 ' A' ' 41' ' ' VAL . 11.6 mmt -92.42 0.6 57.46 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.306 -0.871 . . . . 3.3399999999999999 111.55 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 42' ' ' PRO . 7.5 p -55.12 -2.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 113.598 0.962 . . . . 2.2000000000000002 113.598 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.21 33.91 1.11 Allowed Glycine 0 N--CA 1.492 2.415 0 O-C-N 120.415 -1.428 . . . . 0.46000000000000002 109.686 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.47 ' HB2' HD12 ' A' ' 49' ' ' ILE . 46.5 m-70 -143.8 153.47 42.42 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.25 -1.147 . . . . 0.34999999999999998 111.107 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.59 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.92 83.71 2.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.324 -1.361 . . . . 1.1100000000000001 107.324 178.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.5 mp -86.34 123.02 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 1.77 111.136 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.74 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.26 80.86 4.65 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.793 0.806 . . . . 1.0900000000000001 109.543 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.8 m -57.51 132.19 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 115.946 -0.57 . . . . 1.28 110.239 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.587 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 41.0 t80 -75.48 105.35 6.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.439 -0.788 . . . . 2.21 109.268 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -71.27 -1.43 12.72 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.501 -0.749 . . . . 1.8 110.397 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.06 -22.83 8.9 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.732 -2.147 . . . . 0.40000000000000002 107.732 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.6 pttt -140.58 -30.45 0.65 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.015 -0.697 . . . . 2.4300000000000002 110.945 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.74 155.94 43.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.339 -0.851 . . . . 2.1800000000000002 112.123 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.551 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 0.3 OUTLIER -101.27 106.23 17.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.926 -1.139 . . . . 2.1499999999999999 107.926 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.74 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 39.8 t -96.25 100.1 6.29 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.108 -0.995 . . . . 1.3500000000000001 110.173 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.517 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.7 Cg_endo -66.0 89.62 0.24 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 O-C-N 123.832 1.438 . . . . 0.53000000000000003 109.458 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.523 ' CG1' ' CD2' ' A' ' 74' ' ' PHE . 48.2 t -97.46 119.38 45.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.745 -0.661 . . . . 2.0899999999999999 111.065 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.59 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.9 t80 -73.56 104.14 4.42 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.605 -1.257 . . . . 2.1600000000000001 107.605 177.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.628 ' CG2' HG22 ' A' ' 40' ' ' ILE . 2.8 mp -84.08 140.91 15.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.752 0.787 . . . . 1.5800000000000001 111.567 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.1 p -105.89 -159.45 0.7 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.369 -1.345 . . . . 2.0099999999999998 107.369 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.46 19.53 5.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.733 -1.23 . . . . 2.8900000000000001 110.75 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -139.9 -18.93 0.92 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.961 -1.087 . . . . 2.8100000000000001 112.808 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.619 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 8.3 mtt -85.16 -23.23 28.47 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.708 -1.245 . . . . 2.5699999999999998 110.534 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.548 HG23 ' C ' ' A' ' 41' ' ' VAL . 4.1 p -66.21 162.4 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.227 -0.92 . . . . 1.1299999999999999 111.487 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.526 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 115.98 -15.25 16.3 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.504 -0.855 . . . . 0.41999999999999998 111.046 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.599 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 21.1 m-70 -124.3 -82.36 0.64 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.954 -1.321 . . . . 0.67000000000000004 111.315 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.545 ' HD2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.69 -31.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.695 0.759 . . . . 2.2400000000000002 110.368 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.8 OUTLIER 173.58 -15.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 115.486 -0.779 . . . . 1.3799999999999999 110.827 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.59 -17.67 73.06 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.447 -1.061 . . . . 0.76000000000000001 110.447 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 1.5 mt-10 -86.07 -16.41 38.18 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.379 -1.071 . . . . 1.53 109.233 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.619 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 15.3 m-85 -97.01 -19.94 18.4 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.49 -0.929 . . . . 2.21 108.49 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.582 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -133.25 52.31 8.36 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.694 -0.629 . . . . 1.78 110.379 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 50.0 Cg_endo -84.86 50.44 2.9 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.457 1.241 . . . . 1.75 109.916 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.8 m -97.06 64.41 1.97 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.572 -0.705 . . . . 3.4900000000000002 110.282 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.56 -166.69 0.1 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.611 -0.681 . . . . 8.0500000000000007 111.081 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -106.33 163.22 13.01 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.318 -0.864 . . . . 6.7699999999999996 110.306 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 . . . . . 0 N--CA 1.502 2.14 0 O-C-N 121.779 -0.576 . . . . 10.890000000000001 110.691 179.983 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 4.02 109.582 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 p -131.19 136.62 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.585 -0.95 . . . . 2.59 110.239 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.666 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -131.31 146.59 52.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.542 -0.723 . . . . 1.21 110.121 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 39' ' ' THR . 12.7 p -108.58 121.09 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.524 -0.917 . . . . 1.11 108.524 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.696 ' CG ' HG23 ' A' ' 33' ' ' THR . 36.4 t70 -51.35 105.12 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.507 -0.746 . . . . 1.96 111.023 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -66.09 -24.97 66.8 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.728 -0.842 . . . . 1.47 108.728 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -26.88 67.7 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.137 0.494 . . . . 1.41 109.98 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.868 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -80.55 -37.19 31.9 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.186 -1.042 . . . . 0.61 108.186 178.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.868 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.5 mp -64.04 -41.29 97.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.841 -0.537 . . . . 0.6 109.807 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -55.93 -22.5 26.48 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.716 -0.615 . . . . 1.32 110.434 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -101.8 -28.36 12.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.408 -0.808 . . . . 2.9 110.317 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.987 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.8 OUTLIER -74.77 -37.15 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.387 -0.82 . . . . 0.69 111.044 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -62.18 -28.62 69.79 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.951 -1.129 . . . . 1.92 107.951 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -36.02 71.62 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.48 -0.933 . . . . 2.47 108.48 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 2.5 mt -75.49 -25.72 57.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.695 -0.628 . . . . 1.43 109.886 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -83.76 -18.53 37.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.531 -0.73 . . . . 0.51 109.565 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.29 -38.79 17.16 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.574 -0.703 . . . . 0.58 109.813 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -89.27 -26.61 21.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.142 -0.688 . . . . 3.97 109.142 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.57 14.32 47.69 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.128 -1.589 . . . . 0.85 109.128 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 19.6 mt-10 -78.71 126.98 31.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.408 -1.054 . . . . 2.43 110.392 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -101.32 74.79 1.58 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.533 -0.729 . . . . 2.85 109.531 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.87 -153.12 0.51 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.536 -0.727 . . . . 3.7 110.156 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -119.05 152.76 35.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.787 . . . . 0.67 110.928 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.521 HD13 HG23 ' A' ' 19' ' ' VAL . 2.7 mp -125.94 116.51 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.85 -0.796 . . . . 0.65 108.85 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.54 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 5.9 mptt -78.64 156.63 28.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.35 -0.844 . . . . 2.74 111.395 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.696 HG23 ' CG ' ' A' ' 12' ' ' ASP . 11.9 m -142.97 148.42 36.81 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.758 -0.589 . . . . 1.31 110.003 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.625 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -147.68 50.47 1.06 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.329 -0.857 . . . . 0.88 111.053 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.69 -94.33 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.939 -1.101 . . . . 1.15 110.632 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.3 ttm-85 -163.99 -65.36 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.988 -1.07 . . . . 4.36 110.172 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.41 28.99 3.42 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.403 -0.81 . . . . 3.85 109.75 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.5 m -38.4 123.12 1.15 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.562 0.696 . . . . 0.6 112.126 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 69' ' ' HIS . 10.9 m -127.05 161.29 28.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.923 -0.486 . . . . 0.29 109.748 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.793 HG21 HG21 ' A' ' 62' ' ' ILE . 4.3 mp -81.93 167.07 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.286 -0.884 . . . . 0.95 111.227 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.774 HG21 HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -140.04 176.72 2.37 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 109.259 -0.645 . . . . 0.67 109.259 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.643 ' HD2' HG12 ' A' ' 41' ' ' VAL . 42.8 Cg_endo -66.11 -32.76 42.66 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.944 1.497 . . . . 0.61 111.035 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.92 -9.81 42.08 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.637 -0.664 . . . . 2.65 110.612 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.987 ' SD ' HG21 ' A' ' 19' ' ' VAL . 11.6 mmt -92.42 0.6 57.46 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.306 -0.871 . . . . 2.94 111.55 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -55.12 -2.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 113.598 0.962 . . . . 1.47 113.598 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.21 33.91 1.11 Allowed Glycine 0 N--CA 1.492 2.415 0 O-C-N 120.415 -1.428 . . . . 0.39 109.686 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.631 ' HB2' HD11 ' A' ' 49' ' ' ILE . 46.5 m-70 -143.8 153.47 42.42 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.25 -1.147 . . . . 0.28 111.107 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.741 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.92 83.71 2.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.324 -1.361 . . . . 0.38 107.324 178.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' A' ' 47' ' ' HIS . 2.5 mp -86.34 123.02 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 1.02 111.136 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.771 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.26 80.86 4.65 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.793 0.806 . . . . 0.26 109.543 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 51' ' ' VAL . 32.8 m -57.51 132.19 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 115.946 -0.57 . . . . 0.62 110.239 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.625 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 41.0 t80 -75.48 105.35 6.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.439 -0.788 . . . . 1.29 109.268 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -71.27 -1.43 12.72 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.501 -0.749 . . . . 1.8 110.397 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.06 -22.83 8.9 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.732 -2.147 . . . . 0.38 107.732 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.6 pttt -140.58 -30.45 0.65 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.015 -0.697 . . . . 1.94 110.945 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.74 155.94 43.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.339 -0.851 . . . . 2.18 112.123 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.473 ' CE1' ' HD1' ' A' ' 34' ' ' TRP . 0.5 OUTLIER -101.27 106.23 17.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.926 -1.139 . . . . 1.31 107.926 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.771 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 39.8 t -96.25 100.1 6.29 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.108 -0.995 . . . . 0.73 110.173 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.515 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.7 Cg_endo -66.0 89.62 0.24 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 O-C-N 123.832 1.438 . . . . 0.48 109.458 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 58' ' ' VAL . 48.2 t -97.46 119.38 45.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.745 -0.661 . . . . 1.43 111.065 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.741 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.9 t80 -73.56 104.14 4.42 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.605 -1.257 . . . . 1.26 107.605 177.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.8 mp -84.08 140.91 15.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.752 0.787 . . . . 1.58 111.567 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.1 p -105.89 -159.45 0.7 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.369 -1.345 . . . . 1.63 107.369 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.505 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -90.46 19.53 5.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.733 -1.23 . . . . 2.89 110.75 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -139.9 -18.93 0.92 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.961 -1.087 . . . . 2.18 112.808 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.646 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 8.3 mtt -85.16 -23.23 28.47 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.708 -1.245 . . . . 2.01 110.534 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.588 HG21 ' C ' ' A' ' 41' ' ' VAL . 4.1 p -66.21 162.4 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.227 -0.92 . . . . 0.37 111.487 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.499 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 115.98 -15.25 16.3 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.504 -0.855 . . . . 0.42 111.046 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.679 ' O ' HG23 ' A' ' 39' ' ' THR . 23.1 m80 -124.3 -82.36 0.64 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.954 -1.321 . . . . 0.6 111.315 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.633 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.69 -31.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.695 0.759 . . . . 1.75 110.368 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.633 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER 173.58 -15.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 115.486 -0.779 . . . . 0.85 110.827 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.59 -17.67 73.06 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.447 -1.061 . . . . 0.75 110.447 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.609 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.5 mt-10 -86.07 -16.41 38.18 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.379 -1.071 . . . . 1.53 109.233 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.646 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 15.3 m-85 -97.01 -19.94 18.4 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.49 -0.929 . . . . 1.32 108.49 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.598 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -133.25 52.31 8.36 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.694 -0.629 . . . . 1.44 110.379 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 50.0 Cg_endo -84.86 50.44 2.9 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.457 1.241 . . . . 1.75 109.916 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.8 m -97.06 64.41 1.97 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.572 -0.705 . . . . 3.09 110.282 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.56 -166.69 0.1 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.611 -0.681 . . . . 7.48 111.081 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -106.33 163.22 13.01 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.318 -0.864 . . . . 6.47 110.306 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 . . . . . 0 N--CA 1.502 2.14 0 O-C-N 121.779 -0.576 . . . . 10.61 110.691 179.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 4.02 109.582 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 p -131.19 136.62 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.585 -0.95 . . . . 2.59 110.239 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.666 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -131.31 146.59 52.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.542 -0.723 . . . . 1.21 110.121 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 39' ' ' THR . 12.7 p -108.58 121.09 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.524 -0.917 . . . . 1.11 108.524 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.696 ' CG ' HG23 ' A' ' 33' ' ' THR . 36.4 t70 -51.35 105.12 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.507 -0.746 . . . . 1.96 111.023 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -66.09 -24.97 66.8 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.728 -0.842 . . . . 1.47 108.728 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -26.88 67.7 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.137 0.494 . . . . 1.41 109.98 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.868 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -80.55 -37.19 31.9 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.186 -1.042 . . . . 0.61 108.186 178.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.868 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.5 mp -64.04 -41.29 97.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.841 -0.537 . . . . 0.6 109.807 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -55.93 -22.5 26.48 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.716 -0.615 . . . . 1.32 110.434 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -101.8 -28.36 12.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.408 -0.808 . . . . 2.9 110.317 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.987 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.8 OUTLIER -74.77 -37.15 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.387 -0.82 . . . . 0.69 111.044 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -62.18 -28.62 69.79 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.951 -1.129 . . . . 1.92 107.951 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -36.02 71.62 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.48 -0.933 . . . . 2.47 108.48 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 2.5 mt -75.49 -25.72 57.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.695 -0.628 . . . . 1.43 109.886 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -83.76 -18.53 37.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.531 -0.73 . . . . 0.51 109.565 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.29 -38.79 17.16 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.574 -0.703 . . . . 0.58 109.813 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -89.27 -26.61 21.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.142 -0.688 . . . . 3.97 109.142 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.57 14.32 47.69 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.128 -1.589 . . . . 0.85 109.128 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 19.6 mt-10 -78.71 126.98 31.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.408 -1.054 . . . . 2.43 110.392 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -101.32 74.79 1.58 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.533 -0.729 . . . . 2.85 109.531 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.87 -153.12 0.51 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.536 -0.727 . . . . 3.7 110.156 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -119.05 152.76 35.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.787 . . . . 0.67 110.928 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.521 HD13 HG23 ' A' ' 19' ' ' VAL . 2.7 mp -125.94 116.51 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.85 -0.796 . . . . 0.65 108.85 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.54 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 5.9 mptt -78.64 156.63 28.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.35 -0.844 . . . . 2.74 111.395 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.696 HG23 ' CG ' ' A' ' 12' ' ' ASP . 11.9 m -142.97 148.42 36.81 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.758 -0.589 . . . . 1.31 110.003 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.625 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -147.68 50.47 1.06 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.329 -0.857 . . . . 0.88 111.053 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.69 -94.33 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.939 -1.101 . . . . 1.15 110.632 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.3 ttm-85 -163.99 -65.36 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.988 -1.07 . . . . 4.36 110.172 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.41 28.99 3.42 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.403 -0.81 . . . . 3.85 109.75 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.5 m -38.4 123.12 1.15 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.562 0.696 . . . . 0.6 112.126 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 69' ' ' HIS . 10.9 m -127.05 161.29 28.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.923 -0.486 . . . . 0.29 109.748 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.793 HG21 HG21 ' A' ' 62' ' ' ILE . 4.3 mp -81.93 167.07 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.286 -0.884 . . . . 0.95 111.227 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.774 HG21 HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -140.04 176.72 2.37 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 109.259 -0.645 . . . . 0.67 109.259 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.643 ' HD2' HG12 ' A' ' 41' ' ' VAL . 42.8 Cg_endo -66.11 -32.76 42.66 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.944 1.497 . . . . 0.61 111.035 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.92 -9.81 42.08 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.637 -0.664 . . . . 2.65 110.612 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.987 ' SD ' HG21 ' A' ' 19' ' ' VAL . 11.6 mmt -92.42 0.6 57.46 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.306 -0.871 . . . . 2.94 111.55 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -55.12 -2.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 113.598 0.962 . . . . 1.47 113.598 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.21 33.91 1.11 Allowed Glycine 0 N--CA 1.492 2.415 0 O-C-N 120.415 -1.428 . . . . 0.39 109.686 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.631 ' HB2' HD11 ' A' ' 49' ' ' ILE . 46.5 m-70 -143.8 153.47 42.42 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.25 -1.147 . . . . 0.28 111.107 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.741 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.92 83.71 2.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.324 -1.361 . . . . 0.38 107.324 178.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' A' ' 47' ' ' HIS . 2.5 mp -86.34 123.02 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 1.02 111.136 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.771 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.26 80.86 4.65 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.793 0.806 . . . . 0.26 109.543 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 51' ' ' VAL . 32.8 m -57.51 132.19 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 115.946 -0.57 . . . . 0.62 110.239 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.625 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 41.0 t80 -75.48 105.35 6.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.439 -0.788 . . . . 1.29 109.268 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -71.27 -1.43 12.72 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.501 -0.749 . . . . 1.8 110.397 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.06 -22.83 8.9 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.732 -2.147 . . . . 0.38 107.732 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.6 pttt -140.58 -30.45 0.65 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.015 -0.697 . . . . 1.94 110.945 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.74 155.94 43.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.339 -0.851 . . . . 2.18 112.123 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.551 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 0.3 OUTLIER -101.27 106.23 17.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.926 -1.139 . . . . 1.31 107.926 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.771 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 39.8 t -96.25 100.1 6.29 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.108 -0.995 . . . . 0.73 110.173 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.515 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.7 Cg_endo -66.0 89.62 0.24 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 O-C-N 123.832 1.438 . . . . 0.48 109.458 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 58' ' ' VAL . 48.2 t -97.46 119.38 45.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.745 -0.661 . . . . 1.43 111.065 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.741 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.9 t80 -73.56 104.14 4.42 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.605 -1.257 . . . . 1.26 107.605 177.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.8 mp -84.08 140.91 15.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.752 0.787 . . . . 1.58 111.567 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.1 p -105.89 -159.45 0.7 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.369 -1.345 . . . . 1.63 107.369 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.505 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -90.46 19.53 5.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.733 -1.23 . . . . 2.89 110.75 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -139.9 -18.93 0.92 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.961 -1.087 . . . . 2.18 112.808 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.646 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 8.3 mtt -85.16 -23.23 28.47 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.708 -1.245 . . . . 2.01 110.534 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.588 HG21 ' C ' ' A' ' 41' ' ' VAL . 4.1 p -66.21 162.4 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.227 -0.92 . . . . 0.37 111.487 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.499 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 115.98 -15.25 16.3 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.504 -0.855 . . . . 0.42 111.046 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.679 ' O ' HG23 ' A' ' 39' ' ' THR . 21.1 m-70 -124.3 -82.36 0.64 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.954 -1.321 . . . . 0.6 111.315 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.633 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.69 -31.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.695 0.759 . . . . 1.75 110.368 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.633 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER 173.58 -15.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 115.486 -0.779 . . . . 0.85 110.827 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.59 -17.67 73.06 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.447 -1.061 . . . . 0.75 110.447 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.609 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.5 mt-10 -86.07 -16.41 38.18 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.379 -1.071 . . . . 1.53 109.233 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.646 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 15.3 m-85 -97.01 -19.94 18.4 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.49 -0.929 . . . . 1.32 108.49 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.598 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -133.25 52.31 8.36 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.694 -0.629 . . . . 1.44 110.379 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 50.0 Cg_endo -84.86 50.44 2.9 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.457 1.241 . . . . 1.75 109.916 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.8 m -97.06 64.41 1.97 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.572 -0.705 . . . . 3.09 110.282 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.56 -166.69 0.1 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.611 -0.681 . . . . 7.48 111.081 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -106.33 163.22 13.01 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.318 -0.864 . . . . 6.47 110.306 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 . . . . . 0 N--CA 1.502 2.14 0 O-C-N 121.779 -0.576 . . . . 10.61 110.691 179.983 . . . . . . . . 0 0 . 1 stop_ save_